394
Views
26
CrossRef citations to date
0
Altmetric
Miscellaneous

Biochronomer™ technology

&
Pages 169-183 | Published online: 22 Apr 2005

Bibliography

  • HELLER J: Use of polymers in controlled release. In: Sustained and Controlled Release Delivery Systems. ROBINSON JR, LEE VHL (Eds.) Marcel Dekker, New York (1987):179–212.
  • BYENGMOON J, BAE YH, LEE DS, KIM SW: Biodegradable block copolymers as injectable drug-delivery systems. Nature (1997) 388:860–862.
  • •First report of a bioerodible thermogelling material.
  • DAHIYAT BI, RICHARDS M, LEONGKW: Controlled release from poly(phosphoester) matrices. J. Control. Rel. (1995) 33:13–21.
  • HELLER J: Controlled release of biologically active compounds from bioerodible polymers. Biomaterieds (1980) 1:51–57.
  • Von BURKESRODA F, SCHEDL L, GOPFERICH A: Why degradable polymers undergo surface erosion or bulk erosion. Biomaterials (2002) 23:4221–4231.
  • DADSETAN M, CHRISTENSON EM, UNGER F et al.: In vivo biocompatibility and biodegradation of poly(ethylene carbonate). J. Control. Rel. (2003) 93: 259–270.
  • ACEMOGLU M, NIMMERFALL F, BANTLE S, STOLL GH: Poly(ethylene carbonate)s, part I: Synthesis and structural effects on biodegradation. J. Control. Rel. (1995) 49: 263–276.
  • STOLL GH, NIMMERFALL F, ACEMOGLU M et al.: Poly(ethylene carbonate)s, part II: degradation mechanisms and parenteral delivery of bioactive agents. J. Control. Rel. (2001) 76:209–225.
  • YOLLES S, ELDRIDGE JE, WOODLAND JHR: Sustained delivery of drugs from polymer/drug mixtures. Polym. News (1970) 1:9–12.
  • ••First reported use of bioerodible polymersfor drug delivery
  • KULKARNI RK, MOORE EG, HEGYELI AF, LEONARD F: Biodegradable poly(lactic acid) polymers J. Biomed Mater. Res. (1971) 5:169–181.
  • HUGGINS C, STEVENS RE, HODGES CV: Studies on prostatic cancer. II. The effect of castration in advanced carcinoma of the prostate gland. Arch. Surg. (1941) 43:209–223.
  • KHAN MA, HEALY MS, BERNSTEIN H: Low temperature fabrication of protein-loaded microspheres. Proc. Int. Symp. Control. Rel. Bioact. Mater. (1992) 19:518–519.
  • JOHNSON OFL, CLELAND JF, LEE HJ et al.: A month-long effect from a single injection of microencapsulated human growth hormone. Nat. Med. (1996) 2:795–799.
  • SCHINDLER A, JEFFCOAT R, KIMMELGL, PITT CG, WALL ME, ZWEIDINGER R: Biodegradable polymers for sustained drug delivery. In: Contemporary Topics in Polymer Science. Pearce EM, Schaefgen JR (Eds) Plenum Press, New York (1977) 2:251–289.
  • PITT CG, GRATZL MM, JEFFCOAT AR, ZWEIDINGER R, SCHINDLER A: Sustained drug delivery systems II. Factors affecting release rates from poly(c-caprolactone) and related biodegradable polyesters. J. Pharm. Sci. (1979) 68:1534–1538.
  • PERRIN D, ENGLISH J: Polycaprolactone: Handbook of Biodegradable Polymers - Drug Targeting and Delivery. DOMB A, KOST J, WISEMAN D (Eds) Harwood Academic Publishers, 7000 Chur, Switzerland (1997) 7:63–78.
  • BUCHER JE, SLADE WC: The anhydrides of isophthalic and terephthalic acids. J. Am. Chem. Soc., (1909) 31:1319–1321.
  • •First reported synthesis of a polyanhydride.
  • ROSEN HB, CHANG J, WNEK GE, LINHARDT RJ, LANGER R: Bioerodible polyanhydrides for controlled drug delivery. Biomateriak (1983) 4:131–133.
  • •First report of polyanhydrides as a drug delivery system.
  • LEONG KW, BROTT BC, LANGER R: Bioerodible polyanhydrides as drug carrier matrices I: Characterization, degradation and release characteristics. J. Biomed Mater. Res. (1985) 19:941–955.
  • LEONG KW, D' Bioerodible polyanhydrides as drug carrier matrices II: Biocompatibility and chemical reactivity. J. Biomed Mater. Res. (1986) 20:51–64.
  • BREM H, LANGER R: Polymer-based drug delivery to the brain. Science d'-• Medicine (1996) 3:2–11.
  • ••Early review of brain implant as a new treatment modality.
  • DOMB A, MANIAR M: Absorbable biopolymers derived from dimer fatty acid. J. Polymer Sci., Part A: Polymer Chem. (1993) 31:1275–1285.
  • LI LC, DENG J, STEPHENS D: Polyanhydride implants for antibiotic delivery- from bench to the clinic. Adv. Drug Deli v. Rev. (2002) 54:963–968.
  • TEOMIN D, NYSKA A, DOMB A: Ricinoleic acid-based biopolymers. Biomed. Mater. Res. (1999) 45:258–276.
  • HELLER J, BARR J: Poly(ortho esters) - from concept to reality. Biomacromolecules (2004) 5:1625–1632.
  • •Description of poly(ortho ester) development and rationale for diketene acetal selection.
  • HELLER J: Poly(ortho esters). Adv. in Polymer Sci. (1993) 107: 41–92.
  • •Review of poly(ortho esters) prior to 1992.
  • HELLER J, BARR J, NG SY, SCHWACH-ABDELLAOUI K, GURNY R: Poly(ortho esters): Synthesis, characterization, properties and uses. Adv. Drug Deliv. Rev. (2002) 54:1015–1039.
  • •Review of poly(ortho esters) from 1992.
  • NGUYEN TH, HIMMELSTEIN KJ, HIGUCHI T: Some equilibrium and kinetics of water sorption in poly(ortho esters). Int. J. Pharm. (1985) 25: 1–12.
  • SCHWACH-ABDELLAOUI K, HELLER J, GURNY R: Hydrolysis and erosion studies of autocatalyzed poly(ortho ester) containing lactoyl-lactyl acid dimers. Macromolecules (1999) 32:301–307.
  • •Evidence of predominant surface erosion.
  • ROTHEN-WEINHOLD A. SCHWACH-ABDELLAOUI K, BARR J et al.: Release of BSA from poly(ortho ester) extruded thin strands. J. Control. Rel. (2001) 71:31–37.
  • ZENTNER GM, RATHI, R, SHIH C et al.: Biodegradable block copolymers for the delivery of proteins and water-insoluble drugs. J. Control. Rel., (2000) 72:203–215.
  • •Good discussion of thermogelling materials.
  • ROYALS MA, FUJITA SM, YEWEY GL, RODRIGUEZ J, SCHULTHEISS PC, DUNN RL: Biocompatibility of a biodegradable in situ forming implant system in rhesus monkeys. J. Biomed. Mater. Res. (1999) 45:231–239.
  • •Good discussion of implant formation by polymer precipitation.
  • SCHWACH-ABDELLAOUI K, GURNY R, HELLER J, BARR J: Control of molecular weight for autocatalyzed poly(ortho esters) obtained by polycondensation reaction. Int. J. Polym. Anal. Charact. (2002) 7:145–161.
  • TUCKER GT, MATHER LE: Clinical pharmacokinetics of local anaesthetics. Clin. Pharmacokinet. (1979) 4:241–248.
  • COATES k ABRAHAM S, KAYE SB et al.: On the receiving end - patient perception of the side-effects of cancer chemotherapy. Eur. j Cancer Clin. OncoL (1983) 19:203–208.
  • TRIOZZI PL, LASZLO J: Optimum management of nausea and vomiting in cancer chemotherapy. Drugs (1987) 34:136–149.
  • DUBENSKY TW, LIU MA, ULMER JB: Delivery systems for gene-based vaccines. MoL Med. (2000) 6:723–732.
  • SINGH M, O'HAGAN D: Advances in vaccine adjuvants. Nat. BiotechnoL (1999) 17:1075–1081.
  • WANG C, QING GE, TING D et al.: Molecularly engineered poly(ortho ester) microspheres for enhanced delivery of DNA vaccines. Nature Materials (2004) 3:190–196.
  • •Discussion of DNA plasmid release from poly(ortho esters).
  • KISSEL T, LI YX, VOLLAND C, GORICH S, KONEBERG R: Parenteral protein delivery systems using biodegradable polyesters of ABA block structure, containing hydrophobic poly(lactide-co-glycolide) A blocks and hydrophilic poly(ethylene oxide) B blocks. J. Control. Release (1996) 39:315–326.
  • PISTEL KF, BREITENBACH A, ZANGE-VOLLAND R, KISSEL T: Brush-like branched biodegradable polyesters, part III. Protein release from microspheres of poly(vinyl alcohol)-g-poly(D,L-lactic-co-glycolic acid). J. Control. Release (2001) 73:7–20.
  • DOMB AJ, LANGER R: Solid-state andsolution stability of polyanhydrides and polyesters. Macromolecules (1989) 22:2117–2122.
  • ROHR UD, MARKMANN S, OBERHOFF C et al.: ONCOGELTm; a technological break through in local treatment of paclitaxel sensitive cancers. Proc. Int. Symp. Control. Rel. Bioact. Mater. (2002) 29: 33–34.
  • ZHAO Z, CHAUBAL M, SU G, JIANG T, DANG W: In vitro degradation studies of polylactofates — a copolymer of lactide and phosphate. Proc. Int. Symp. Control. Rel. Bioact. Mater. (2000) 27:652–653.
  • BYEONGMOON J, KIBBEY MR, BIRNBAUM C, WON Y-Y, GUTOWSKA A: Thermogelling biodegradable polymers with hydrophilic backbones: PEG-g-PLGA. Macromolecules (2000) 33:8317–8322.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.